231 related articles for article (PubMed ID: 28666544)
41. New technologies personalize diagnostics and therapeutics.
Rosenson RS
Curr Atheroscler Rep; 2010 May; 12(3):184-6. PubMed ID: 20425257
[TBL] [Abstract][Full Text] [Related]
42. The Emerging Therapeutic Role of NGF in Alzheimer's Disease.
Xu CJ; Wang JL; Jin WL
Neurochem Res; 2016 Jun; 41(6):1211-8. PubMed ID: 26801170
[TBL] [Abstract][Full Text] [Related]
43. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.
Faustino C; Rijo P; Reis CP
Pharmacol Res; 2017 Jun; 120():68-87. PubMed ID: 28351757
[TBL] [Abstract][Full Text] [Related]
44. Nanotechnological applications for the treatment of neurodegenerative disorders.
Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
[TBL] [Abstract][Full Text] [Related]
45. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease.
Sun D; Li N; Zhang W; Zhao Z; Mou Z; Huang D; Liu J; Wang W
Colloids Surf B Biointerfaces; 2016 Dec; 148():116-129. PubMed ID: 27591943
[TBL] [Abstract][Full Text] [Related]
46. Emerging implications of nanotechnology on cancer diagnostics and therapeutics.
Cuenca AG; Jiang H; Hochwald SN; Delano M; Cance WG; Grobmyer SR
Cancer; 2006 Aug; 107(3):459-66. PubMed ID: 16795065
[TBL] [Abstract][Full Text] [Related]
47. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
48. Alzheimer's disease and dementia.
Meador KJ
J Med Assoc Ga; 1993 Sep; 82(9):495-9. PubMed ID: 8228681
[TBL] [Abstract][Full Text] [Related]
49. Renovating Alzheimer's: "constructive" reflections on the new clinical and research diagnostic guidelines.
George DR; Qualls SH; Camp CJ; Whitehouse PJ
Gerontologist; 2013 Jun; 53(3):378-87. PubMed ID: 22936533
[TBL] [Abstract][Full Text] [Related]
50. Advances in clinical research in Alzheimer's disease.
Weiner MF
Compr Ther; 1991 Aug; 17(8):9-13. PubMed ID: 1742981
[TBL] [Abstract][Full Text] [Related]
51. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
52. The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.
Wimo A
J Alzheimers Dis; 2018; 64(s1):S41-S46. PubMed ID: 29710714
[TBL] [Abstract][Full Text] [Related]
53. Gene Therapy Models of Alzheimer's Disease and Other Dementias.
Combs B; Kneynsberg A; Kanaan NM
Methods Mol Biol; 2016; 1382():339-66. PubMed ID: 26611599
[TBL] [Abstract][Full Text] [Related]
54. Advances in Alzheimer's disease. A review for the family physician.
Roth ME
J Fam Pract; 1993 Dec; 37(6):593-607. PubMed ID: 8245812
[TBL] [Abstract][Full Text] [Related]
55. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
56. Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.
Dubois B; Padovani A; Scheltens P; Rossi A; Dell'Agnello G
J Alzheimers Dis; 2016; 49(3):617-31. PubMed ID: 26484931
[TBL] [Abstract][Full Text] [Related]
57. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
58. Alzheimer's Disease: Pathogenesis and Therapeutic Interventions.
Ogbodo JO; Agbo CP; Njoku UO; Ogugofor MO; Egba SI; Ihim SA; Echezona AC; Brendan KC; Upaganlawar AB; Upasani CD
Curr Aging Sci; 2022; 15(1):2-25. PubMed ID: 33653258
[TBL] [Abstract][Full Text] [Related]
59. Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools.
Di Carlo M; Giacomazza D; San Biagio PL
J Phys Condens Matter; 2012 Jun; 24(24):244102. PubMed ID: 22595372
[TBL] [Abstract][Full Text] [Related]
60. Potential applications of nanotechnologies to Parkinson's disease therapy.
Linazasoro G;
Parkinsonism Relat Disord; 2008; 14(5):383-92. PubMed ID: 18329315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
